European Radiology

, Volume 27, Issue 7, pp 2679–2688 | Cite as

Altered intrinsic brain activity after chemotherapy in patients with gastric cancer: A preliminary study

  • Hyun Gi Kim
  • Na-Young Shin
  • Yunjin Bak
  • Kyung Ran Kim
  • Young-Chul Jung
  • Kyunghwa Han
  • Seung-Koo Lee
  • Soo Mee Lim



To characterize the pattern of altered intrinsic brain activity in gastric cancer patients after chemotherapy (CTx).


Patients before and after CTx (n = 14) and control subjects (n = 11) underwent resting-state functional MRI (rsfMRI) at baseline and 3 months after CTx. Regional homogeneity (ReHo), amplitude of low-frequency fluctuation (ALFF), and fractional ALFF (fALFF) were calculated and compared between the groups using the two-sample t test. Correlation analysis was also performed between rsfMRI values (i.e., ReHo, ALFF, and fALFF) and neuropsychological test results.


Patients showed poor performance in verbal memory and executive function and decreased rsfMRI values in the frontal areas even before CTx and showed decreased attention/working memory and executive function after CTx compared to the control subjects. In direct comparison of values before and after CTx, there were no significant differences in neuropsychological test scores, but decreased rsfMRI values were observed at the frontal lobes and right cerebellar region. Among rsfMRI values, lower ALFF in the left inferior frontal gyrus was significantly associated with poor performance of the executive function test.


We observed decreased attention/working memory and executive function that corresponded to the decline of frontal region activation in gastric cancer patients who underwent CTx.

Key Points

Intrinsic brain activity of gastric cancer patients after chemotherapy was described.

Brain activity and neuropsychological test results were correlated.

Working memory and executive function decreased after chemotherapy.

Decreased cognitive function corresponded to decreased activation of the frontal region.


Gastric cancer Cancer chemotherapy agents Functional magnetic resonance imaging Brain Cognitive function 



The scientific guarantor of this publication is Na-Young Shin. The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. This work was supported by the Ewha Womans University Research Grant of 2015 (1-2015-0437-001-1). One of the authors has significant statistical expertise (Kyunghwa Han). Institutional review board approval was obtained. Written informed consent was obtained from all subjects (patients) in this study. Methodology: prospective, case-control study, performed at one institution.

Supplementary material

330_2016_4578_MOESM1_ESM.docx (53 kb)
Supplementary Table 1 (DOCX 52.7 kb)


  1. 1.
    Wefel JS, Schagen SB (2012) Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep 12:267–275CrossRefPubMedGoogle Scholar
  2. 2.
    de Ruiter MB, Schagen SB (2013) Functional MRI studies in non-CNS cancers. Brain Imaging Behav 7:388–408CrossRefPubMedGoogle Scholar
  3. 3.
    McDonald BC, Conroy SK, Smith DJ, West JD, Saykin AJ (2013) Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study. Brain Behav Immun 30:S117–S125CrossRefPubMedGoogle Scholar
  4. 4.
    Monje M, Dietrich J (2012) Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis. Behav Brain Res 227:376–379CrossRefPubMedGoogle Scholar
  5. 5.
    Conroy SK, McDonald BC, Smith DJ, Moser LR, West JD, Kamendulis LM et al (2013) Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage. Breast Cancer Res Treat 137:493–502CrossRefPubMedGoogle Scholar
  6. 6.
    Hogervorst E (2013) Effects of gonadal hormones on cognitive behaviour in elderly men and women. J Neuroendocrinol 25:1182–1195CrossRefPubMedGoogle Scholar
  7. 7.
    Correia SC, Santos RX, Cardoso S, Carvalho C, Santos MS, Oliveira CR et al (2010) Effects of estrogen in the brain: is it a neuroprotective agent in Alzheimer's disease? Curr Aging Sci 3:113–126CrossRefPubMedGoogle Scholar
  8. 8.
    Seigers R, Timmermans J, van der Horn HJ, de Vries EF, Dierckx RA, Visser L et al (2010) Methotrexate reduces hippocampal blood vessel density and activates microglia in rats but does not elevate central cytokine release. Behav Brain Res 207:265–272CrossRefPubMedGoogle Scholar
  9. 9.
    O'Shaughnessy JA (2003) Chemotherapy-induced cognitive dysfunction: a clearer picture. Clin Breast Cancer 4:S89–S94CrossRefPubMedGoogle Scholar
  10. 10.
    Kesler S, Hadi Hosseini SM, Heckler C, Janelsins M, Palesh O, Mustian K et al (2013) Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors. Clin Breast Cancer 13:299–306CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Von Ah D, Carpenter JS, Saykin A, Monahan P, Wu J, Yu M et al (2012) Advanced cognitive training for breast cancer survivors: a randomized controlled trial. Breast Cancer Res Treat 135:799–809CrossRefGoogle Scholar
  12. 12.
    Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65:5–29CrossRefPubMedGoogle Scholar
  13. 13.
    Fock KM, Ang TL (2010) Epidemiology of Helicobacter pylori infection and gastric cancer in Asia. J Gastroenterol Hepatol 25:479–486CrossRefPubMedGoogle Scholar
  14. 14.
    Dhobi MA, Wani KA, Parray FQ, Wani RA, Wani ML, Peer GQ et al (2013) Gastric cancer in young patients. Int J Surg Oncol 2013:981654PubMedPubMedCentralGoogle Scholar
  15. 15.
    Zang Y, Jiang T, Lu Y, He Y, Tian L (2004) Regional homogeneity approach to fMRI data analysis. Neuroimage 22:394–400CrossRefPubMedGoogle Scholar
  16. 16.
    Zuo XN, Xu T, Jiang L, Yang Z, Cao XY, He Y et al (2013) Toward reliable characterization of functional homogeneity in the human brain: preprocessing, scan duration, imaging resolution and computational space. Neuroimage 65:374–386CrossRefPubMedGoogle Scholar
  17. 17.
    Fox MD, Raichle ME (2007) Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci 8:700–711CrossRefPubMedGoogle Scholar
  18. 18.
    Zou QH, Zhu CZ, Yang Y, Zuo XN, Long XY, Cao QJ et al (2008) An improved approach to detection of amplitude of low-frequency fluctuation (ALFF) for resting-state fMRI: fractional ALFF. J Neurosci Methods 172:137–141CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Friston KJ, Williams S, Howard R, Frackowiak RS, Turner R (1996) Movement-related effects in fMRI time-series. Magn Reson Med 35:346–355CrossRefPubMedGoogle Scholar
  20. 20.
    Kendall MG, Gibbons JD (1990) Rank correlation methods, 5th edn. Oxford University Press, OxfordGoogle Scholar
  21. 21.
    Chao-Gan Y, Yu-Feng Z (2010) DPARSF: a MATLAB toolbox for “pipeline” data analysis of resting-state fMRI. Front Syst Neurosci 4Google Scholar
  22. 22.
    Jung MS, Zhang M, Askren MK, Berman MG, Peltier S, Hayes DF et al (2016) Cognitive dysfunction and symptom burden in women treated for breast cancer: a prospective behavioral and fMRI analysis. Brain Imaging Behav. doi: 10.1007/s11682-016-9507-8 PubMedGoogle Scholar
  23. 23.
    Wefel JS, Saleeba AK, Buzdar AU, Meyers CA (2010) Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 116:3348–3356CrossRefPubMedGoogle Scholar
  24. 24.
    Stewart A, Collins B, Mackenzie J, Tomiak E, Verma S, Bielajew C (2008) The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study. Psychooncology 17:122–130CrossRefPubMedGoogle Scholar
  25. 25.
    Shilling V, Jenkins V, Morris R, Deutsch G, Bloomfield D (2005) The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study. Breast 14:142–150CrossRefPubMedGoogle Scholar
  26. 26.
    Kane MJ, Engle RW (2002) The role of prefrontal cortex in working-memory capacity, executive attention, and general fluid intelligence: an individual-differences perspective. Psychon Bull Rev 9:637–671CrossRefPubMedGoogle Scholar
  27. 27.
    McDonald BC, Conroy SK, Ahles TA, West JD, Saykin AJ (2012) Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study. J Clin Oncol 30:2500–2508CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, van Dam FS, Nederveen AJ et al (2011) Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Hum Brain Mapp 32:1206–1219CrossRefPubMedGoogle Scholar
  29. 29.
    Deprez S, Amant F, Yigit R, Porke K, Verhoeven J, Van den Stock J et al (2011) Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Hum Brain Mapp 32:480–493CrossRefPubMedGoogle Scholar
  30. 30.
    Abraham J, Haut MW, Moran MT, Filburn S, Lemiuex S, Kuwabara H (2008) Adjuvant chemotherapy for breast cancer: effects on cerebral white matter seen in diffusion tensor imaging. Clin Breast Cancer 8:88–91CrossRefPubMedGoogle Scholar
  31. 31.
    Winocur G, Vardy J, Binns MA, Kerr L, Tannock I (2006) The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice. Pharmacol Biochem Behav 85:66–75CrossRefPubMedGoogle Scholar
  32. 32.
    Dietrich J, Han R, Yang Y, Mayer-Pröschel M, Noble M (2006) CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol 5:1CrossRefGoogle Scholar
  33. 33.
    Seigers R, Loos M, Van Tellingen O, Boogerd W, Smit AB, Schagen SB (2016) Neurobiological changes by cytotoxic agents in mice. Behav Brain Res 299:19–26CrossRefPubMedGoogle Scholar
  34. 34.
    Liu C, Chen Z, Wang T, Tang D, Hitchman G, Sun J et al (2015) Predicting stroop effect from spontaneous neuronal activity: a study of regional homogeneity. PLoS One 10:e0124405CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Milham MP, Banich MT, Barad V (2003) Competition for priority in processing increases prefrontal cortex's involvement in top-down control: an event-related fMRI study of the stroop task. Brain Res Cogn Brain Res 17:212–222CrossRefPubMedGoogle Scholar
  36. 36.
    Hamilton AC, Martin RC (2005) Dissociations among tasks involving inhibition: a single-case study. Cogn Affect Behav Neurosci 5:1–13CrossRefPubMedGoogle Scholar
  37. 37.
    Diasio RB (2000) Oral DPD-inhibitory fluoropyrimidine drugs. Oncology (Williston Park) 14:19–23Google Scholar
  38. 38.
    Gemma C, Bachstetter AD (2013) The role of microglia in adult hippocampal neurogenesis. Front Cell Neurosci 7:229CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Sharpe MJ, Fardell JE, Vardy J, Johnston IN (2012) The chemotherapy agent oxaliplatin impairs the renewal of fear to an extinguished conditioned stimulus in rats. Behav Brain Res 227:295–299CrossRefPubMedGoogle Scholar
  40. 40.
    Bernard JA, Mittal VA (2014) Cerebellar-motor dysfunction in schizophrenia and psychosis-risk: the importance of regional cerebellar analysis approaches. Front Psychiatry 5:160CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Askren MK, Jung M, Berman MG, Zhang M, Therrien B, Peltier S et al (2014) Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigation. Breast Cancer Res Treat 147:445–455CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Berman MG, Askren MK, Jung M, Therrien B, Peltier S, Noll DC et al (2014) Pretreatment worry and neurocognitive responses in women with breast cancer. Health Psychol 33:222CrossRefPubMedGoogle Scholar
  43. 43.
    Cimprich B, Reuter-Lorenz P, Nelson J, Clark PM, Therrien B, Normolle D et al (2010) Prechemotherapy alterations in brain function in women with breast cancer. J Clin Exp Neuropsychol 32:324–331CrossRefPubMedGoogle Scholar
  44. 44.
    Hedayati E, Schedin A, Nyman H, Alinaghizadeh H, Albertsson M (2011) The effects of breast cancer diagnosis and surgery on cognitive functions. Acta Oncol 50:1027–1036CrossRefPubMedGoogle Scholar
  45. 45.
    Hermelink K, Untch M, Lux MP, Kreienberg R, Beck T, Bauerfeind I et al (2007) Cognitive function during neoadjuvant chemotherapy for breast cancer. Cancer 109:1905–1913CrossRefPubMedGoogle Scholar
  46. 46.
    Wefel JS, Lenzi R, Theriault R, Buzdar AU, Cruickshank S, Meyers CA (2004) ‘Chemobrain’in breast carcinoma?: a prologue. Cancer 101:466–475CrossRefPubMedGoogle Scholar
  47. 47.
    Newman S, Stygall J, Hirani S, Shaefi S, Maze M (2007) Postoperative cognitive dysfunction after noncardiac surgery: a systematic review. Anesthesiology 106:572–590CrossRefPubMedGoogle Scholar
  48. 48.
    Xie P, Yu T, Fu X, Tu Y, Zou Y, Lui S et al (2013) Altered functional connectivity in an aged rat model of postoperative cognitive dysfunction: a study using resting-state functional MRI. PLoS One 8:e64820CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Perouansky M, Hemmings HC Jr (2009) Neurotoxicity of general anesthetics: cause for concern? Anesthesiology 111:1365–1371CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Valentin LS, Pereira VF, Pietrobon RS, Schmidt AP, Oses JP, Portela LV et al (2016) Effects of single low dose of dexamethasone before noncardiac and nonneurologic surgery and general anesthesia on postoperative cognitive dysfunction-a phase III double blind, randomized clinical trial. PLoS One 11:e0152308CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Bhattacharyya PK, Lowe MJ (2004) Cardiac-induced physiologic noise in tissue is a direct observation of cardiac-induced fluctuations. Magn Reson Imaging 22:9–13CrossRefPubMedGoogle Scholar
  52. 52.
    Lowe MJ, Mock BJ, Sorenson JA (1998) Functional connectivity in single and multislice echoplanar imaging using resting-state fluctuations. Neuroimage 7:119–132CrossRefPubMedGoogle Scholar

Copyright information

© European Society of Radiology 2017

Authors and Affiliations

  • Hyun Gi Kim
    • 1
  • Na-Young Shin
    • 2
    • 3
  • Yunjin Bak
    • 2
  • Kyung Ran Kim
    • 4
  • Young-Chul Jung
    • 4
  • Kyunghwa Han
    • 3
  • Seung-Koo Lee
    • 3
  • Soo Mee Lim
    • 2
  1. 1.Department of Radiology, Ajou University School of MedicineAjou University Medical CenterSuwonKorea
  2. 2.Department of RadiologyEwha Womans University School of MedicineSeoulKorea
  3. 3.Department of Radiology, Research Institute of Radiological ScienceYonsei University College of MedicineSeoulKorea
  4. 4.Department of PsychiatryYonsei University College of MedicineSeoulKorea

Personalised recommendations